HDAC1/HDAC3 modulates PPARG2 transcription through the sumoylated CEBPD in hepatic lipogenesis

Pei Hua Lai, Wen Lin Wang, Chiung Yuan Ko, Yi Chao Lee, Wen Ming Yang, Tsung Wei Shen, Wen Chang Chang, Ju Ming Wang

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

CCAAT/Enhancer binding proteins (C/EBPs) and peroxisome proliferator-activated receptors gamma (PPARG) play critical roles in the regulation of lipid metabolism genes. Overexpression of CEBPdelta (CEBPD) enhances lipid accumulation and specifically activates PPARG2 transcription in HepG2 cells. By using 5′-serial deletion reporter analysis, we show that the region comprising the - 457 to + 129 base pairs is required for CEBPD response of the PPARG2 promoter. Two critical CEBPD-binding motifs on the - 324/- 311 and - 158/- 145 of human PPARG2 promoter are identified. We previously have shown that the human CEBPD is sumoylated by small ubiquitin-related modifier-1 (SUMO1). We further demonstrated that the sumoylation of CEBPD lysine 120 is also detectable in HepG2 cells, and this modification functions for binding of the recruits, HDAC1 and HDAC3. Meanwhile, an in vivo chromatin IP assay demonstrated that the sumoylation mutant of CEBPD lost a significant portion of HDAC1 and HDAC3 interaction. Combining that the increasing amount of CEBPD and the sumoylated CEBPD (suCEBPD) consistently responded to lipogenic stimulation, these results suggest that the excess non-sumoylated CEBPD could be a critical activator which reverses suCEBPD/HDAC1/HDAC3-mediated PPARG2 gene inactivation and promotes hepatic lipogenesis. Taken together, we suggest that suCEBPD/HDAC1/HDAC3 complex inactivates PPARG2 transcription, and the induction of CEBPD expression transiently activates PPARG2 transcription which is involved in adipocyte-like lipogenesis in HepG2 cells.

Original languageEnglish
Pages (from-to)1803-1814
Number of pages12
JournalBiochimica et Biophysica Acta - Molecular Cell Research
Volume1783
Issue number10
DOIs
Publication statusPublished - Oct 2008
Externally publishedYes

Fingerprint

Lipogenesis
Hep G2 Cells
Sumoylation
Liver
CCAAT-Enhancer-Binding Proteins
PPAR gamma
Gene Silencing
Ubiquitin
Lipid Metabolism
Adipocytes
Base Pairing
Lysine
Chromatin
Lipids
Genes

Keywords

  • CEBPD
  • HDAC1/3
  • Lipogenesis
  • PPARG2
  • Sumoylation

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Biophysics

Cite this

HDAC1/HDAC3 modulates PPARG2 transcription through the sumoylated CEBPD in hepatic lipogenesis. / Lai, Pei Hua; Wang, Wen Lin; Ko, Chiung Yuan; Lee, Yi Chao; Yang, Wen Ming; Shen, Tsung Wei; Chang, Wen Chang; Wang, Ju Ming.

In: Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1783, No. 10, 10.2008, p. 1803-1814.

Research output: Contribution to journalArticle

@article{acd9e8f7334b42c6be19bdffb90174f4,
title = "HDAC1/HDAC3 modulates PPARG2 transcription through the sumoylated CEBPD in hepatic lipogenesis",
abstract = "CCAAT/Enhancer binding proteins (C/EBPs) and peroxisome proliferator-activated receptors gamma (PPARG) play critical roles in the regulation of lipid metabolism genes. Overexpression of CEBPdelta (CEBPD) enhances lipid accumulation and specifically activates PPARG2 transcription in HepG2 cells. By using 5′-serial deletion reporter analysis, we show that the region comprising the - 457 to + 129 base pairs is required for CEBPD response of the PPARG2 promoter. Two critical CEBPD-binding motifs on the - 324/- 311 and - 158/- 145 of human PPARG2 promoter are identified. We previously have shown that the human CEBPD is sumoylated by small ubiquitin-related modifier-1 (SUMO1). We further demonstrated that the sumoylation of CEBPD lysine 120 is also detectable in HepG2 cells, and this modification functions for binding of the recruits, HDAC1 and HDAC3. Meanwhile, an in vivo chromatin IP assay demonstrated that the sumoylation mutant of CEBPD lost a significant portion of HDAC1 and HDAC3 interaction. Combining that the increasing amount of CEBPD and the sumoylated CEBPD (suCEBPD) consistently responded to lipogenic stimulation, these results suggest that the excess non-sumoylated CEBPD could be a critical activator which reverses suCEBPD/HDAC1/HDAC3-mediated PPARG2 gene inactivation and promotes hepatic lipogenesis. Taken together, we suggest that suCEBPD/HDAC1/HDAC3 complex inactivates PPARG2 transcription, and the induction of CEBPD expression transiently activates PPARG2 transcription which is involved in adipocyte-like lipogenesis in HepG2 cells.",
keywords = "CEBPD, HDAC1/3, Lipogenesis, PPARG2, Sumoylation",
author = "Lai, {Pei Hua} and Wang, {Wen Lin} and Ko, {Chiung Yuan} and Lee, {Yi Chao} and Yang, {Wen Ming} and Shen, {Tsung Wei} and Chang, {Wen Chang} and Wang, {Ju Ming}",
year = "2008",
month = "10",
doi = "10.1016/j.bbamcr.2008.06.008",
language = "English",
volume = "1783",
pages = "1803--1814",
journal = "Biochimica et Biophysica Acta - Molecular Cell Research",
issn = "0167-4889",
publisher = "Elsevier",
number = "10",

}

TY - JOUR

T1 - HDAC1/HDAC3 modulates PPARG2 transcription through the sumoylated CEBPD in hepatic lipogenesis

AU - Lai, Pei Hua

AU - Wang, Wen Lin

AU - Ko, Chiung Yuan

AU - Lee, Yi Chao

AU - Yang, Wen Ming

AU - Shen, Tsung Wei

AU - Chang, Wen Chang

AU - Wang, Ju Ming

PY - 2008/10

Y1 - 2008/10

N2 - CCAAT/Enhancer binding proteins (C/EBPs) and peroxisome proliferator-activated receptors gamma (PPARG) play critical roles in the regulation of lipid metabolism genes. Overexpression of CEBPdelta (CEBPD) enhances lipid accumulation and specifically activates PPARG2 transcription in HepG2 cells. By using 5′-serial deletion reporter analysis, we show that the region comprising the - 457 to + 129 base pairs is required for CEBPD response of the PPARG2 promoter. Two critical CEBPD-binding motifs on the - 324/- 311 and - 158/- 145 of human PPARG2 promoter are identified. We previously have shown that the human CEBPD is sumoylated by small ubiquitin-related modifier-1 (SUMO1). We further demonstrated that the sumoylation of CEBPD lysine 120 is also detectable in HepG2 cells, and this modification functions for binding of the recruits, HDAC1 and HDAC3. Meanwhile, an in vivo chromatin IP assay demonstrated that the sumoylation mutant of CEBPD lost a significant portion of HDAC1 and HDAC3 interaction. Combining that the increasing amount of CEBPD and the sumoylated CEBPD (suCEBPD) consistently responded to lipogenic stimulation, these results suggest that the excess non-sumoylated CEBPD could be a critical activator which reverses suCEBPD/HDAC1/HDAC3-mediated PPARG2 gene inactivation and promotes hepatic lipogenesis. Taken together, we suggest that suCEBPD/HDAC1/HDAC3 complex inactivates PPARG2 transcription, and the induction of CEBPD expression transiently activates PPARG2 transcription which is involved in adipocyte-like lipogenesis in HepG2 cells.

AB - CCAAT/Enhancer binding proteins (C/EBPs) and peroxisome proliferator-activated receptors gamma (PPARG) play critical roles in the regulation of lipid metabolism genes. Overexpression of CEBPdelta (CEBPD) enhances lipid accumulation and specifically activates PPARG2 transcription in HepG2 cells. By using 5′-serial deletion reporter analysis, we show that the region comprising the - 457 to + 129 base pairs is required for CEBPD response of the PPARG2 promoter. Two critical CEBPD-binding motifs on the - 324/- 311 and - 158/- 145 of human PPARG2 promoter are identified. We previously have shown that the human CEBPD is sumoylated by small ubiquitin-related modifier-1 (SUMO1). We further demonstrated that the sumoylation of CEBPD lysine 120 is also detectable in HepG2 cells, and this modification functions for binding of the recruits, HDAC1 and HDAC3. Meanwhile, an in vivo chromatin IP assay demonstrated that the sumoylation mutant of CEBPD lost a significant portion of HDAC1 and HDAC3 interaction. Combining that the increasing amount of CEBPD and the sumoylated CEBPD (suCEBPD) consistently responded to lipogenic stimulation, these results suggest that the excess non-sumoylated CEBPD could be a critical activator which reverses suCEBPD/HDAC1/HDAC3-mediated PPARG2 gene inactivation and promotes hepatic lipogenesis. Taken together, we suggest that suCEBPD/HDAC1/HDAC3 complex inactivates PPARG2 transcription, and the induction of CEBPD expression transiently activates PPARG2 transcription which is involved in adipocyte-like lipogenesis in HepG2 cells.

KW - CEBPD

KW - HDAC1/3

KW - Lipogenesis

KW - PPARG2

KW - Sumoylation

UR - http://www.scopus.com/inward/record.url?scp=50849106698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50849106698&partnerID=8YFLogxK

U2 - 10.1016/j.bbamcr.2008.06.008

DO - 10.1016/j.bbamcr.2008.06.008

M3 - Article

VL - 1783

SP - 1803

EP - 1814

JO - Biochimica et Biophysica Acta - Molecular Cell Research

JF - Biochimica et Biophysica Acta - Molecular Cell Research

SN - 0167-4889

IS - 10

ER -